Clinical Trials Logo

Clinical Trial Summary

Participants will perform blood glucose monitoring (BGM) over the course of 14 days and, in parallel, wear continuous glucose monitoring (CGM) systems. Because current CGM systems typically achieve a lower level of analytical accuracy than BGM systems, participants will perform at least 5 blood glucose (BG) measurements per day. In addition, CGM systems are used to obtain minimally-invasive high-frequency glucose measurements to fill the gaps between BG measurements.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Assessment of Glucose Concentrations
  • Diabetes Mellitus
  • Subjects Without Diabetes Mellitus

NCT number NCT03405415
Study type Interventional
Source Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm
Contact
Status Completed
Phase N/A
Start date January 27, 2018
Completion date July 10, 2019